These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15304081)

  • 21. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
    Tereskerz PM; Moreno J
    Account Res; 2005; 12(2):139-55. PubMed ID: 16220626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression.
    Cosgrove L; Krimsky S; Wheeler EE; Peters SM; Brodt M; Shaughnessy AF
    Account Res; 2017; 24(2):99-115. PubMed ID: 27901595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doctors' groups are criticised for endorsing pro-industry guidelines.
    Arie S
    BMJ; 2013 Oct; 347():f6066. PubMed ID: 24107354
    [No Abstract]   [Full Text] [Related]  

  • 24. Can a good tree bring forth evil fruit? The funding of medical research by industry.
    Capps B
    Br Med Bull; 2016 Jun; 118(1):5-15. PubMed ID: 27151955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conflicts of interest with the health industry.
    Dubois MY
    Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609
    [No Abstract]   [Full Text] [Related]  

  • 26. Conflicts-of-interest disclosures at the 2010 AUGS Scientific Meeting.
    Ramm O; Brubaker L
    Female Pelvic Med Reconstr Surg; 2012; 18(2):79-81. PubMed ID: 22453315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new method for scoring financial conflicts of interest.
    Maharaj SV
    Int J Occup Environ Health; 2015; 21(1):49-52. PubMed ID: 25633929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
    Puttagunta PS; Caulfield TA; Griener G
    Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust.
    Johns MM; Barnes M; Florencio PS
    JAMA; 2003 Feb; 289(6):741-6. PubMed ID: 12585953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Financial disclosure for review authors.
    Nat Neurosci; 2003 Oct; 6(10):997. PubMed ID: 14513027
    [No Abstract]   [Full Text] [Related]  

  • 31. Financial conflicts of interest in human subjects research: the problem of institutional conflicts.
    Barnes M; Florencio PS
    J Law Med Ethics; 2002; 30(3):390-402. PubMed ID: 12497699
    [No Abstract]   [Full Text] [Related]  

  • 32. Conflicts of interest: honours or honoraria.
    Sivakumaran M
    Lancet; 2003 Sep; 362(9387):922. PubMed ID: 13678996
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial policies on financial disclosure.
    Carroll BJ; Rubin RT
    Nat Neurosci; 2003 Oct; 6(10):999-1000; author reply 1000-1. PubMed ID: 14513028
    [No Abstract]   [Full Text] [Related]  

  • 34. Relationships between medicine and industry: approaches to the problem of conflicts of interest.
    Raad R; Appelbaum PS
    Annu Rev Med; 2012; 63():465-77. PubMed ID: 21888513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach.
    Coleman DL; Kazdin AE; Miller LA; Morrow JS; Udelsman R
    Acad Med; 2006 Feb; 81(2):154-60. PubMed ID: 16436576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Handling conflicts of interest between industry and academia.
    Egilman DS; Ehrle LH
    JAMA; 2003 Jun; 289(24):3240; author reply 3240-1. PubMed ID: 12824203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science].
    Ludwig WD; Hildebrandt M; Schott G
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(3):149-54. PubMed ID: 19554889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A turning point for conflicts of interest: the controversy over the National Academy of Sciences' first conflicts of interest disclosure policy.
    Parascandola M
    J Clin Oncol; 2007 Aug; 25(24):3774-9. PubMed ID: 17704427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innovation incentives or corrupt conflicts of interest? Moving beyond Jekyll and Hyde in regulating biomedical academic-industry relationships.
    Taylor PL
    Yale J Health Policy Law Ethics; 2013; 13(1):135-97. PubMed ID: 23815042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial policies on financial disclosure.
    Jacobson MF; Sharpe VA; Angell M; Ashford NA; Blum A; Chary LK; Cho M; Coull BC; Davis D; Doolittle RF; Egilman D; Epstein SS; Greenberg M; Hooper K; Huff J; Joshi TK; Krimsky S; LaDou J; Levenstein C; Miles S; Needleman H; Pellegrino ED; Ravanesi B; Sass J; Schecter A; Schneiderman JS; Schubert D; Soffritti M; Suzuki D; Takaro TK; Temple NJ; Terracini B; Thompson A; Wallinga D; Wing S
    Nat Neurosci; 2003 Oct; 6(10):1001. PubMed ID: 14513030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.